Trademark: MYELOID TARGETING PLATFORM
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
MYELOID TARGETING PLATFORM
Click here to search for trademarks similar to MYELOID TARGETING PLATFORM
Proof of use for MYELOID TARGETING PLATFORM
We do not have any records of a proof of use for MYELOID TARGETING PLATFORM at this moment.
Click here to add a proof of use for MYELOID TARGETING PLATFORM
Possible trademark infringements of MYELOID TARGETING PLATFORM
Basic Information about MYELOID TARGETING PLATFORM
- Serial Number
- 98086316
- Filing Date
- 14 Jul 2023
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of MYELOID TARGETING PLATFORM on the blockchain with WikiTrademarks.io.
- First use of MYELOID TARGETING PLATFORM anywhere
- MYELOID TARGETING PLATFORM was first used on 03 Jun 2024 for the primary classification of goods and services, international, 042 (Computer, scientific & legal)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 042
- US Codes
- 100; 101
Who owns MYELOID TARGETING PLATFORM?
1. UNITED IMMUNITY, CO., LTD. Tokyo
Correspondent
- Boris Umansky LADAS & PARRY LLP
- 224 S. MICHIGAN AVE., STE. 1600
- CHICAGO, IL 60604
- United States
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io